OBJECTIVES: To clarify whether patients with spinal muscular atrophy (SMA) or spinal and bulbar muscular atrophy (SBMA) suffer disabling muscle fatigue, and whether activity-dependent conduction block (ADCB) contributes to their fatigue. ADCB is usually caused by reduced safety factor for impulse transmission in demyelinating diseases, whereas markedly increased axonal branching associated with collateral sprouting may reduce the safety factor in chronic lower motor neuron disorders. METHODS: We assessed the fatigue severity scale (FSS) in 22 patients with SMA/SBMA, and in 100 disease controls (multiple sclerosis, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy (CIDP), and axonal neuropathy). We then performed stimulated-single fibre electromyography (s-SFEMG) in the extensor digitorum communis (EDC) muscle of 21 SMA/SBMA patients, 6 CIDP patients, and 10 normal subjects. RESULTS: The FSS score was the highest in SMA/SBMA patients [4.9 ± 1.1 (mean ± SD)], with 81% of them complaining of disabling fatigue, compared with normal controls (3.5 ± 1.0), whereas patients with multiple sclerosis (4.3 ± 1.6), myasthenia gravis (4.0 ± 1.6) or CIDP (4.3 ± 1.4) also showed higher FSS score. When 2000 stimuli were delivered at 20 Hz in s-SFEMG, conduction block of single motor axons developed in 46% of patients with SMA/SBMA, and 40% of CIDP patients, but in none of the normal controls. CONCLUSION: SMA/SBMA patients frequently suffer from disabling fatigue presumably caused by ADCB induced by voluntary activity. SIGNIFICANCE: ADCB could be the mechanism for muscle fatigue in chronic lower motor neuron diseases.
OBJECTIVES: To clarify whether patients with spinal muscular atrophy (SMA) or spinal and bulbar muscular atrophy (SBMA) suffer disabling muscle fatigue, and whether activity-dependent conduction block (ADCB) contributes to their fatigue. ADCB is usually caused by reduced safety factor for impulse transmission in demyelinating diseases, whereas markedly increased axonal branching associated with collateral sprouting may reduce the safety factor in chronic lower motor neuron disorders. METHODS: We assessed the fatigue severity scale (FSS) in 22 patients with SMA/SBMA, and in 100 disease controls (multiple sclerosis, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy (CIDP), and axonal neuropathy). We then performed stimulated-single fibre electromyography (s-SFEMG) in the extensor digitorum communis (EDC) muscle of 21 SMA/SBMApatients, 6 CIDPpatients, and 10 normal subjects. RESULTS: The FSS score was the highest in SMA/SBMApatients [4.9 ± 1.1 (mean ± SD)], with 81% of them complaining of disabling fatigue, compared with normal controls (3.5 ± 1.0), whereas patients with multiple sclerosis (4.3 ± 1.6), myasthenia gravis (4.0 ± 1.6) or CIDP (4.3 ± 1.4) also showed higher FSS score. When 2000 stimuli were delivered at 20 Hz in s-SFEMG, conduction block of single motor axons developed in 46% of patients with SMA/SBMA, and 40% of CIDPpatients, but in none of the normal controls. CONCLUSION: SMA/SBMApatients frequently suffer from disabling fatigue presumably caused by ADCB induced by voluntary activity. SIGNIFICANCE: ADCB could be the mechanism for muscle fatigue in chronic lower motor neuron diseases.
Authors: Kentaro Oki; Katherine Halievski; Laura Vicente; Youfen Xu; Donald Zeolla; Jessica Poort; Masahisa Katsuno; Hiroaki Adachi; Gen Sobue; Robert W Wiseman; S Marc Breedlove; Cynthia L Jordan Journal: J Appl Physiol (1985) Date: 2015-02-05
Authors: K Kizina; B Stolte; A Totzeck; S Bolz; M Schlag; C Ose; O von Velsen; C Kleinschnitz; Tim Hagenacker Journal: Sci Rep Date: 2020-07-06 Impact factor: 4.379
Authors: Julia R Dahlqvist; Sofie T Oestergaard; Nanna S Poulsen; Kirsten Lykke Knak; Carsten Thomsen; John Vissing Journal: Sci Rep Date: 2019-03-18 Impact factor: 4.379
Authors: Bart Bartels; Laura E Habets; Marloes Stam; Renske I Wadman; Camiel A Wijngaarde; Marja A G C Schoenmakers; Tim Takken; Erik H J Hulzebos; W Ludo van der Pol; Janke F de Groot Journal: BMC Neurol Date: 2019-02-09 Impact factor: 2.474